Introduction
============

Inflammatory bowel diseases, including Crohn\'s disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract commonly associated with high morbidity. The precise etiology of inflammatory bowel diseases is unknown, but involves a complex combination of host genetic, microbial, and environmental factors that alter mucosal immune responses.^[@bib1]^

In healthy individuals, intestinal homeostasis is ensured through the tight control of aberrant immune responses by a complex regulatory network. Distinct subsets of mononuclear phagocytes (MNPs) are strategically located at the mucosal interface, residing either in gut-associated lymphoid tissue or dispersed throughout the lamina propria. Within these sites, two major populations of MNPs can be identified:^[@bib2]^ classical dendritic cells (DCs), expressing the integrins CD11c and CD103 (α~E~β~7~) with or without coexpression of CD11b, and monocyte-derived MNPs, expressing the fractalkine receptor (CX~3~CR1), CD11b, and various levels of CD11c. In addition, two minor populations of DCs can be found: CD103^-^ CD11b^+^ CX~3~CR1^int^ and CD103^-^ CD11b^-^ CX~3~CR1^-^ DCs.^[@bib3]^ Lamina propria CD103^+^ DCs arise from common DC progenitors and classical DC-committed precursor under the control of Fms-like tyrosine kinase 3 ligand. CD103^+^ CD11b^+^ DCs are predominantly located in the small intestine, where they constitutively sample antigen and migrate to the mesenteric lymph nodes to prime and polarize naive T cells.^[@bib4],\ [@bib5]^ In contrast, the colon mostly harbors CD103^+^ CD11b^-^ DCs^[@bib6]^ that are developmentally related to lymphoid-tissue resident CD8α^+^ DCs.^[@bib7]^

In addition to classical DCs, a network of macrophages expressing high levels of CD11c and CX~3~CR1 is spread throughout the intestinal lamina propria. These cells contrast with macrophage populations in other tissues by their relatively short life span and their constitutive replenishment from the blood monocyte pool.^[@bib8],\ [@bib9],\ [@bib10]^ Under homeostatic conditions, Ly6C^hi^ monocytes entering the gut transit through a continuum of developmental intermediates before giving rise to fully mature CX~3~CR1^hi^ macrophages. This process involves the stepwise acquisition of anti-inflammatory genes along with the expression of the major histocompatibility complex class II (MHCII) and downregulation of typical proinflammatory genes.^[@bib11],\ [@bib12]^ Ly6C^hi^ monocytes also give rise to a heterogeneous Ly6C^lo^ CX~3~CR1^int^ cellular subset distinct from macrophages that share characteristics of macrophages and DCs^[@bib11],\ [@bib13]^ and can be distinguished by their differential expression of the tissue macrophage marker Fc gamma receptor 1 (CD64)^[@bib14],\ [@bib15]^ and F4/80.

Lately, many studies have highlighted the critical roles of these complementary subsets in shaping both homeostatic and inflammatory responses.^[@bib5],\ [@bib16],\ [@bib17]^ Their precise roles in inflammation are only beginning to be unraveled, and definitive reports on their functional contribution to chronic intestinal inflammation are currently lacking.

Interleukin-23 (IL-23) is a heterodimeric cytokine comprising the IL-12p40 and IL-23p19 subunits.^[@bib18]^ It has been well documented as a critical driver of multiple inflammatory conditions in mice and humans, and plays a key role in the pathogenesis of inflammatory bowel diseases.^[@bib19],\ [@bib20]^ Although the mechanism through which IL-23 drives intestinal inflammation has been studied extensively, little is known about the cellular sources implicated in the generation of IL-23-dependent intestinal inflammation *in vivo*. In this study, we used a bacterially driven model of intestinal inflammation with many cardinal features of human inflammatory bowel diseases to address the functional relevance of IL-23 production by CD11c^+^ antigen-presenting cells and to characterize the cellular subsets involved in this key pathophysiological process.

Results
=======

*H. hepaticus*-driven inflammation alters the intestinal mononuclear phagocyte compartment
------------------------------------------------------------------------------------------

The Gram-negative bacterium *Helicobacter hepaticus* (*Hh*) is a noninvasive organism commonly found in the mucosal layer of the murine lower intestinal tract. Wild-type animals infected with the bacterium do not develop intestinal immunopathology and serve as carriers of the infection.^[@bib21]^ However, mice with genetic deficiencies in the IL-10/IL-10R pathway are susceptible to experimental *Hh* infection and develop severe inflammation of the colon and cecum (typhlocolitis) associated with epithelial hyperplasia.^[@bib22],\ [@bib23]^ Similarly, *Hh* infection of wild-type mice with concomitant administration of anti-IL-10R monoclonal antibodies (mAbs) triggers IL-23-dependent intestinal inflammation along with a robust T helper type 1/type 17 (Th1/Th17)-polarized effector T cell response.^[@bib23]^ Mice infected with *Hh* and treated with anti-IL-10R antibodies, but not uninfected or single-treated controls, develop histological features of colitis within 2--3 weeks after infection ([Figure 1a](#fig1){ref-type="fig"}). *Hh* and anti-IL-10R-treated mice further show a marked infiltration of leukocytes within the lamina propria ([Figure 1b](#fig1){ref-type="fig"}), including predominant populations of neutrophils and MHCII^+^ monocytes ([Figure 1c](#fig1){ref-type="fig"} and [Supplementary Figure S1a](#sup1){ref-type="supplementary-material"} online). In the noninflamed colon, monocytes entering the lamina propria from the blood preferentially give rise to tissue macrophages^[@bib11]^ (defined as CD11b^+^ CX~3~CR1^hi^ Ly6C^lo^ cells, green subset), expressing high levels of CD64, MHCII, F4/80 and CD11c ([Figure 1d](#fig1){ref-type="fig"} and [Supplementary Figure S1b](#sup1){ref-type="supplementary-material"}). However, this process is dramatically altered during inflammation and we observed the marked accumulation of MHCII^+^ monocytes (defined as CD11b^+^ CX~3~CR1^int^ Ly6C^hi^ cells, red subset) within the colonic lamina propria. These cells are characterized by the expression of CD64 and MHCII and intermediate levels of F4/80, CD24, and CD11c ([Figure 1c--e](#fig1){ref-type="fig"} and [Supplementary Figure S1a](#sup1){ref-type="supplementary-material"}). At steady state, MHCII^+^ monocytes and macrophages express the mannose receptor (CD206), a marker associated with anti-inflammatory macrophage function.^[@bib24]^ However, expression of CD206 was lower in MHCII^+^ monocytes and macrophages during colitis ([Figure 1f](#fig1){ref-type="fig"}), suggesting that not only monocyte but also macrophage functions were modified during inflammation. Indeed, we found that during inflammation, MHCII^+^ monocytes expressed higher amounts of tumor necrosis factor-α and IL-6 protein, and *Nos2* (inducible nitric oxide synthase) mRNA, and that IL-6 was also increased in macrophages ([Supplementary Figure S1c](#sup1){ref-type="supplementary-material"}). IL-10 production by both MHCII^+^ monocytes and macrophages was also increased during inflammation ([Supplementary Figure S1c](#sup1){ref-type="supplementary-material"}), most likely reflecting an inflammation-driven negative feedback pathway.

Besides their differentiation into macrophages, MHCII^+^ monocytes have also been shown to differentiate into a Ly6C^lo^ CX~3~CR1^int^ heterogeneous subset related to both macrophages and classical DCs.^[@bib11]^ Among this heterogeneous compartment, CD11b^+^ DCs (defined as CD11c^+^ CD103^-^ CD11b^+^ CX~3~CR1^int^ cells, gray subset) can easily be distinguished from macrophages under homeostatic conditions. CD11b^+^ DCs express MHCII, CD24, and CD11c, but lack expression of CD64 and F4/80, markers commonly associated with macrophages ([Figure 1d](#fig1){ref-type="fig"} and [Supplementary Figure S1b](#sup1){ref-type="supplementary-material"}). However, the distinction between macrophages and CD11b^+^ DCs was blurred during inflammation by the appearance of a CD64-expressing population ([Figure 1d,e](#fig1){ref-type="fig"}) and it is currently unclear how these cells ontogenically and functionally relate to steady-state macrophages or CD11b^+^ DCs.

During colitis, the marked accumulation of MHCII^+^ monocytes correlated with a reduced frequency of macrophages, CD11b^+^ DCs, and CD103^+^ DCs (defined as CD11c^+^ CD103^+^ CX~3~CR1^-^ cells, orange subset) among CD45^+^ lamina propria cells ([Figure 1c,d](#fig1){ref-type="fig"}). However, absolute numbers indicated a small increase in CD11b^+^ DCs and CD103^+^ CD11b^+^ DCs. In contrast, the numbers of macrophages remained unchanged and CD103^+^ CD11b^-^ DCs were slightly decreased ([Supplementary Figure S1a](#sup1){ref-type="supplementary-material"}).

Altogether, *Hh* infection in the presence of IL-10R blockade triggers intestinal inflammation associated with dramatic changes in the myeloid compartment. We observed the predominant accumulation of granulocytes and MHCII^+^ monocytes within the colonic lamina propria. In addition, MHCII^+^ monocytes and macrophages acquired a more proinflammatory profile.

CD11c^+^ mononuclear phagocytes drive colitis through the production of IL-23
-----------------------------------------------------------------------------

Because IL-23 has been identified as the major driver of colitis in this model,^[@bib23]^ we next investigated the functional relevance of IL-23 production by mononuclear phagocytes in the development of colitis in the *Hh*+anti-IL-10R model. Therefore, we crossed mice expressing green fluorescent protein (GFP) and *Cre* recombinase under the control of the CD11c promoter (encoded by *Itgax*)^[@bib25],\ [@bib26]^ with mice possessing two loxP sites flanking four exons of the *Il23a* gene^[@bib27]^ to generate *Cd11c-cre.Il23a*^fl/fl^ (CD11c^IL-23-^) mice.

As CD11c^IL-23-^ mice express GFP under the control of the CD11c promoter and therefore cannot be crossed to CX~3~CR1-GFP reporter mice, we relied on an alternative gating strategy to assess the myeloid compartment in these mice ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). At steady state, CD11c^IL-23-^ mice had similar numbers of leukocytes in the colon as their IL-23-proficient littermates (CD11c^IL-23+^) ([Supplementary Figure S3a](#sup1){ref-type="supplementary-material"}) and no significant changes in the frequencies of myeloid or T cells were observed ([Supplementary Figure S3b](#sup1){ref-type="supplementary-material"}). However, as IL-23 is required for maintaining differentiated Th17 cells,^[@bib28]^ CD11c^IL-23-^ mice displayed strongly reduced levels of IL-17^+^ and IL-17^+^ IFNγ^+^ CD4^+^ T cells in the colon ([Supplementary Figure S3c](#sup1){ref-type="supplementary-material"}).

Upon infection with *Hh* and anti-IL-10R treatment, CD11c^IL-23-^ mice exhibited a striking reduction in colitis compared with CD11c^IL-23+^ mice, with reduced epithelial crypt hyperplasia and lower leukocyte infiltration throughout the colon and cecum ([Figure 2a,b](#fig2){ref-type="fig"}). CD11c^IL-23-^ mice also showed no development of splenomegaly ([Figure 2c](#fig2){ref-type="fig"}), indicating that they were also protected from systemic signs of disease. Reduced pathology observed in CD11c^IL-23-^ mice was not a consequence of a differential bacterial load, as *Hh* colonization levels were similar in CD11c^IL-23-^ and CD11c^IL-23+^ groups ([Figure 2d](#fig2){ref-type="fig"}). Consistent with reduced pathological changes, both innate and adaptive effector cytokines were strongly reduced in the colon of CD11c^IL-23-^ mice following *Hh* and IL-10R blockade ([Figure 2e](#fig2){ref-type="fig"}), as was the amount of IL-23 itself ([Figure 2f](#fig2){ref-type="fig"}).

In accordance with their reduced leukocyte infiltration, CD11c^IL-23-^ mice showed a reduced frequency and number of both MHCII^-^ and MHCII^+^ monocytes ([Figure 3a](#fig3){ref-type="fig"}) and neutrophils ([Supplementary Figure S3d](#sup1){ref-type="supplementary-material"}) within the lamina propria following *Hh* infection and IL-10R blockade compared with similarly treated CD11c^IL-23+^ littermates. The lower infiltration of monocytes in CD11c^IL-23-^ mice correlated with a higher frequency of lamina propria macrophages, whereas the frequencies of CD11b^+^ DCs and CD103^+^ DCs were unchanged and absolute numbers were reduced ([Supplementary Figure S3d](#sup1){ref-type="supplementary-material"}).

Because IL-23 drives intestinal inflammation through direct effects on T cells, promoting their accumulation and proliferation in the colon,^[@bib29]^ we examined the colonic T cell compartment of CD11c^IL-23-^ and CD11c^IL-23+^ mice during colitis. CD11c^IL-23-^ mice displayed lower frequencies of colonic CD4^+^ T cells compared with their IL-23-proficient littermates ([Figure 3b](#fig3){ref-type="fig"}). Whereas CD11c^IL-23+^ mice mounted a robust Th1/Th17 effector response characterized by the emergence of single- and double-producing IL-17A^+^/IFNγ^+^ T cells, CD11c^IL-23-^ mice showed only mild induction of the corresponding cytokines ([Figure 3c](#fig3){ref-type="fig"}).

Overall, the absence of colitis in CD11c^IL-23-^ mice indicates that the production of IL-23 by CD11c-expressing MNPs plays a nonredundant role in the intestinal inflammatory response.

MHCII^+^ monocytes and macrophages are the major source of IL-23 upon *H. hepaticus* infection
----------------------------------------------------------------------------------------------

To better understand the sequence of events associated with the development of colitis in IL-23-proficient mice, we first monitored IL-23 expression in leukocytes purified from the colonic lamina propria. *Il23a* mRNA expression was consistently detectable 4--5 days following initiation of colitis ([Figure 4a](#fig4){ref-type="fig"}), suggesting that a tissue-resident and/or a rapidly mobilized cellular subset is involved in the early production of IL-23 in the colon. We therefore chose this time point for subsequent analyses. At 4 days after infection with *Hh* and anti-IL-10R treatment, CD11c^IL-23+^ mice showed an increased infiltration of leukocytes in the lamina propria relative to uninfected control mice ([Figure 4b](#fig4){ref-type="fig"}). This influx correlated with increased numbers of all MNP subsets in the colon ([Supplementary Figure S4a,b](#sup1){ref-type="supplementary-material"}), as well as increased frequencies of both MHCII^-^ and MHCII^+^ monocytes ([Figure 4c,d](#fig4){ref-type="fig"}), neutrophils ([Figure 4d](#fig4){ref-type="fig"}), CD103^+^ CD11b^-^ DCs, and CD103^+^ CD11b^+^ DCs ([Figure 4e](#fig4){ref-type="fig"}). However, frequencies of macrophages and CD11b^+^ DCs among total leukocytes were unchanged at this time point ([Figure 4d](#fig4){ref-type="fig"}).

To further characterize the myeloid subsets involved in IL-23-dependent intestinal inflammation, we examined CD11c-Cre-associated GFP expression by lamina propria cells from CD11c^IL-23+^ mice. Analysis of CD45^+^ cells confirmed that Cre-GFP expression was restricted to leukocytes expressing CD11c on their cell surface ([Figure 4f](#fig4){ref-type="fig"}), but was predominantly observed in CD11c^hi^ cells. Furthermore, Cre-associated GFP fluorescence was only observed in MHCII^+^ cells ([Figure 4g](#fig4){ref-type="fig"}) and, interestingly, *Il23a* mRNA expression was restricted to Cre-GFP^+^ cells ([Figure 4h](#fig4){ref-type="fig"}). The majority of lamina propria MNPs express high levels of CD11c ([Figure 1e](#fig1){ref-type="fig"} and [Supplementary Figure S1b](#sup1){ref-type="supplementary-material"}). Analysis of distinct myeloid subsets in CD11c^IL-23+^ mice revealed that CD11c-Cre-associated GFP expression was predominantly detected among macrophages, CD103^+^ CD11b^-^ DCs, CD103^+^ CD11b^+^ DCs, ([Figure 4i](#fig4){ref-type="fig"}), and CD11b^+^ DCs (not shown). In addition, more than half of MHCII^+^ monocytes were positive for Cre-GFP, indicating that all those subsets might be a potential source of IL-23. In contrast, Cre expression was absent from eosinophils, neutrophils, and MHCII^-^ monocytes ([Figure 4i](#fig4){ref-type="fig"}).

To characterize which of these subsets represent a functional source of IL-23 *in vivo*, we assessed *Il23a* mRNA expression by the corresponding populations sorted by flow cytometry from CD11c^IL-23-^ and CD11c^IL-23+^ mice 4 days after *Hh* infection in the presence of IL-10R blockade. Strikingly, *Il23a* mRNA expression in CD11c^IL-23+^ cells was mostly restricted to MHCII^+^ monocytes and macrophages, with low expression detectable among CD103^+^ CD11b^-^ DCs and CD103^+^ CD11b^+^ DCs ([Figure 4j](#fig4){ref-type="fig"}). Furthermore, *Il23a* expression by both MHCII^+^ monocytes and macrophages was markedly reduced in CD11c^IL-23-^ mice, indicating that CD11c-Cre-expression was active within these cellular subsets ([Figure 4j](#fig4){ref-type="fig"}). The low *Il23a* expression observed in MHCII^-^ monocytes ([Figure 4k](#fig4){ref-type="fig"}) suggests that induction of IL-23 occurs in the lamina propria during their local maturation and acquisition of MHCII.

As the level of CX~3~CR1 expression identifies discrete subsets of MNPs, we repeated our analysis in CX~3~CR1^GFP/+^ mice. In uninfected mice, low levels of constitutive *Il23a* were detected among MHCII^+^ monocytes, CD103^+^ CD11b^+^ DCs, ([Supplementary Figure S4c,d](#sup1){ref-type="supplementary-material"}), and CD11b^+^ DCs ([Supplementary Figure S4d](#sup1){ref-type="supplementary-material"}). However, increased expression of *Il23a* at 4 days following infection with *Hh* and IL-10R blockade was only consistently detected in MHCII^+^ monocytes ([Supplementary Figure S4d](#sup1){ref-type="supplementary-material"}) and macrophages (not shown). During the course of inflammation, high *Il23a* expression was maintained in MHCII^+^ monocytes and their developmental progeny, but not CD103^+^ DCs ([Figure 5a](#fig5){ref-type="fig"}). Among CX~3~CR1^int^ subsets, expression of *Il23a* was further restricted to CD64^+^ cells ([Figure 5b](#fig5){ref-type="fig"}).

Taken together, our data indicate that induction of IL-23 in colitis is contained within CX~3~CR1-expressing CD11c^+^ cells that also express MHCII and CD64.

*Batf3*-dependent CD103^+^ DCs are dispensable for chronic colitis
------------------------------------------------------------------

CD103^+^ CD11b^+^ DCs are predominantly found in the mouse small intestine and are nearly absent from the colon.^[@bib6]^ Instead, most colonic CD103^+^ DCs are CD11b^-^ and require the transcription factor *Batf3* for their development.^[@bib30]^ *Batf3*^−/−^ mice therefore lack tissue-resident CD8α^+^ and CD103^+^ CD11b^-^ nonlymphoid DC subsets. As expected, CD103^+^ CD11b^-^ cells were strongly reduced in the colonic lamina propria of *Batf3*^−/−^ mice, whereas CD103^+^ CD11b^+^ DCs were unaffected ([Figure 6a,b](#fig6){ref-type="fig"}). To assess whether CD103^+^ CD11b^-^ DCs might be involved in the development of colitis, we infected *Batf3*^−/−^ mice with *Hh* combined with anti-IL-10R treatment. At 2 weeks after initiation of colitis, numbers of CD103^+^ CD11b^-^ DCs were still significantly reduced in the lamina propria ([Figure 6b](#fig6){ref-type="fig"}), but no differences in leukocyte infiltration ([Figure 6c](#fig6){ref-type="fig"}) or severity of colitis ([Figure 6d](#fig6){ref-type="fig"}) were observed in *Batf3*^−/−^ mice compared with their wild-type counterparts, indicating that *Batf3*-dependent DCs are dispensable for the induction of IL-23-driven intestinal inflammation in this model.

Mature macrophages produce IL-23 in response to *H. hepaticus* stimulation *in vitro*, but share functional redundancy with MHCII^+^ monocytes *in vivo*
--------------------------------------------------------------------------------------------------------------------------------------------------------

To decipher the contribution of macrophages to IL-23 production, we generated bone marrow-derived macrophages (BMDMs) from CD11c^IL-23-^ and CD11c^IL-23+^ mice. After differentiation with L929 cell-conditioned medium, around half of the BMDMs were positive for Cre-GFP and expressed CD64, F4/80, and CD11c ([Supplementary Figure S5a](#sup1){ref-type="supplementary-material"}). BMDMs were stimulated *in vitro* with live *Hh* bacteria in the presence of anti-IL-10R antibody and their response was compared with the respective controls. Strikingly, stimulation of CD11c^IL-23+^ BMDMs with *Hh* resulted in *Il23a* mRNA expression and this response was enhanced in the presence of IL-10R signaling blockade, whereas *Il23a* was not expressed by unstimulated BMDMs or those treated with anti-IL-10R antibody alone ([Supplementary Figure S5b](#sup1){ref-type="supplementary-material"}). Similarly, infection of mice with *Hh* only induced a low burst of IL-23 in monocytes and macrophages *in vivo* and this response was strongly increased in the absence of IL-10R signaling ([Supplementary Figure S5c](#sup1){ref-type="supplementary-material"}).

Intestinal tissue macrophages exclusively derive from blood monocytes and do not self-renew.^[@bib8],\ [@bib10]^ Colony-stimulating factor 1 receptor (CSF-1R) signaling controls the differentiation of Ly6C^hi^ into Ly6C^lo^ monocytes^[@bib31]^ and is required for the maturation and replacement of resident-type Ly6C^lo^ monocytes and tissue macrophages, but is dispensable for Ly6C^hi^ monocyte production or inflammatory function.^[@bib32]^ To assess the relative contributions of MHCII^+^ monocytes and tissue macrophages to the development of IL-23-dependent intestinal inflammation, we pretreated CX~3~CR1^GFP/+^ mice with an anti-CSF-1R-blocking mAb or isotype control before induction of colitis. A group of mice was analyzed at day 0 ([Supplementary Figure S6a,b](#sup1){ref-type="supplementary-material"}), whereas the remaining mice were treated with *Hh* and anti-IL-10R and continued to receive anti-CSF-1R treatment. At 4 days after *Hh* infection and anti-IL-10R treatment, macrophages were almost absent from the colon of anti-CSF-1R-treated mice. The heterogeneous Ly6C^lo^ CX~3~CR1^int^ macrophage/DC compartment was also significantly reduced in these mice ([Figure 7a,b](#fig7){ref-type="fig"} and [Supplementary Figure S6c](#sup1){ref-type="supplementary-material"}). Although the total number of colonic leukocytes was unchanged ([Figure 7c](#fig7){ref-type="fig"}), there was an increase in the proportion of granulocytes in these conditions ([Figure 7d](#fig7){ref-type="fig"}). Interestingly, the depletion of macrophages further correlated with increased *Il23a* expression within the lamina propria at day 4 ([Figure 7e](#fig7){ref-type="fig"}). However, anti-CSF-1R-mediated depletion of macrophages throughout the whole course of colitis did not affect the number of inflammatory cells accumulating in the colon ([Figure 7f](#fig7){ref-type="fig"}) or the severity of intestinal pathology ([Figure 7g](#fig7){ref-type="fig"}) 2 weeks following *Hh* infection and IL-10R signaling blockade, suggesting that MHCII^+^ monocytes and macrophages may exhibit functional redundancy during inflammation.

Discussion
==========

In this work, we show that intestinal CD11c^+^ mononuclear phagocytes play a nonredundant role in the inflammatory process triggered by *Hh* in the absence of IL-10R signaling through the production of IL-23. Both innate and adaptive immune responses were impaired in the absence of CD11c-restricted IL-23 production, preventing the characteristic intestinal infiltration of granulocytes, monocytes, and pathogenic T cells observed in this model. Multiple lamina propria MNPs express CD11c and analysis of *Il23a* gene expression from various colonic CD11c^+^ subsets identified MHCII^+^ monocytes and macrophages as the most abundant cellular sources of IL-23 during *Hh*+anti-IL-10R-induced inflammation, supporting a functional contribution of these cells during colitis. In contrast, IL-23-driven colitis was independent of *Batf3*-dependent CD103^+^ CD11b^-^ DCs. These results are consistent with our previous studies showing a pathogenic role for infiltrating monocytes during T cell-driven colitis^[@bib16]^ and further show that production of IL-23 is a major determinant of this function.

Others have identified monocytes/macrophages as a source of IL-23 upon intestinal inflammation.^[@bib33],\ [@bib34],\ [@bib35]^ However, none of those studies have examined the relative expression of IL-23 by distinct MNP subsets in a systematic way nor have addressed the functional relevance of this expression in the context of chronic intestinal inflammation. This is mostly because of the difficulty of accurately identifying individual subsets of macrophages and DCs within the lamina propria owing to substantial overlap in their expression of surface markers.

Although CX~3~CR1^hi^ macrophages have been described as a decisive factor determining gut health and inflammation,^[@bib36]^ we have made the intriguing observation that intestinal macrophages dependent on CSF-1 for their survival were dispensable for the production of *Il23a* and development of colitis in our model. This indicates that newly recruited monocytes entering the lamina propria from the blood do not require full differentiation to launch a proinflammatory response and can drive colitis in the absence of macrophages. It further suggests that fully mature macrophages share some functional redundancy with MHCII^+^ monocytes regarding the production of IL-23. This observation is in line with the distinctive origin of intestinal macrophages, which are replenished exclusively from the blood monocyte pool through a series of developmental intermediates.^[@bib10]^ Blood monocytes show induction of MHCII after or in concert with their arrival into tissues, possibly through interaction with the endothelium.^[@bib37]^ Our observation that both MHCII^-^ and CD64^-^ subsets do not express *Il23a* suggests that the induction of IL-23 occurs in a particular, more mature monocyte developmental stage coinciding with the upregulation of MHCII and CD64.

DC-derived IL-23 has been shown to be involved in both homeostatic and inflammatory mucosal functions. Thus, interferon regulatory factor 4-dependent CD103^+^ CD11b^+^ intestinal DCs drive homeostatic Th17 cell differentiation,^[@bib4],\ [@bib38]^ a function associated with increased IL-12/IL-23 production.^[@bib39]^ Similarly, we observed that CD11c^IL-23-^ mice had strongly reduced levels of IL-17A^+^ cells in the colonic lamina propria and low levels of constitutive *Il23a* were detected among colonic CD103^+^ CD11b^+^ DCs and CD11b^+^ DCs during the steady state. In models of acute intestinal inflammation, Notch2-dependent CD103^+^ CD11b^+^ DCs are an obligate source of IL-23 for driving the IL-22-dependent antimicrobial response to infection with the attaching-and-effacing mouse pathogen *Citrobacter rodentium*.^[@bib40]^ CD103^+^ CD11b^+^ DCs of the small intestine were also shown to produce a Toll-like receptor 5-dependent burst of IL-23 at ∼30 min following systemic flagellin administration, suggesting that this subset of DCs can induce IL-23-driven responses upon Toll-like receptor 5 stimulation.^[@bib41]^ In contrast, others have shown that CD103^+^ CD11b^+^ DCs were dispensable for IL-22-mediated protection against C. *rodentium*,^[@bib42]^ whereas depletion of CX~3~CR1^+^ MNPs resulted in more severe colitis and death in *C. rodentium*-infected mice.^[@bib35]^ Together with our own data, these diverging results nicely illustrate that the functional sources of IL-23 that drive host protection or immune pathology vary and are not surprisingly highly context dependent. In our model, the development of colonic inflammation and histopathological changes induced by the noninvasive pathosymbiont *Hh* crucially depends on IL-23 production by CD11c^+^ cells. Induced *Il23a* expression is found at highest amounts in MHCII^+^ monocytes, which combined with their numerical dominance, suggests a major functional role of these cells in the pathogenesis of intestinal inflammation. However, given the ontogenic and phenotypical heterogeneity observed among the lamina propria CD11c^+^ MNP compartment during colitis and the difficulty to accurately distinguish CD11b^+^ DCs from macrophages because of their overlapping CD64 expression in inflammation, we cannot formally rule out a functional contribution of *bona fide* DCs in this model. Further studies specifically targeting the DC lineage will help to clarify this point.

Although IL-23 promotes Th17 responses, it is unclear whether IL-17 itself plays a pathogenic role in IL-10-deficient models of colitis. Indeed, IL-17A production by T cells was dispensable for T cell transfer colitis,^[@bib43]^ and neutralization of IL-17 was not sufficient to inhibit colitis in IL-10-deficient mice, being only partially protective when combined with anti-IL-6 treatment.^[@bib44]^ This suggests that IL-23 can drive IL-17-independent inflammatory pathways in the intestine. Our recent studies have suggested a key role for IL-23-driven granulocyte macrophage-CSF as a major downstream mediator that promotes chronic colitis through its ability to stimulate the myeloid cell response.^[@bib45]^ Others have shown that granulocyte macrophage-CSF can promote IL-23 production by MNPs,^[@bib46]^ suggesting a positive feedback loop that may contribute to T cell-mediated perpetuation of the innate inflammatory response.

Overall, our observation that intestinal CX~3~CR1-expressing CD11c^+^ cells are the major source of IL-23 in a physiological model of bacteria-driven colitis confirms the pathogenic potential of these cells during colitis and uncovers a novel mechanism through which they might perpetuate chronic inflammation. Further understanding of the functional sources of IL-23 in diverse forms of intestinal inflammation may lead to novel therapeutic strategies aimed at interrupting IL-23-driven immune pathology.

Methods
=======

**Mice.** *Itgax-cre-EGFP (Cd11c-cre)*^[@bib25]^ mice express a Cre recombinase gene, IRES, and an EGFP gene downstream of the 5.3 kb (full length) mouse CD11c promoter/enhancer. Expression of EGFP is expected to have equimolar expression with Cre recombinase. The promoter activity of CD11c-Cre-GFP strain 4097 has been described in detail elsewhere.^[@bib26]^ *Itgax-cre-EGFP*,^[@bib25]^ *Il23a*^fl/fl^,^[@bib27]^ *Cd11c-cre.Il23a*^fl/fl^, CX~3~CR1^GFP/+^,^[@bib47]^ and *Batf3*^−/−[@bib30]^ mice were bred and maintained under specific pathogen-free conditions in accredited animal facilities at the University of Oxford. Experiments were conducted in accordance with the UK Scientific Procedures Act (1986) under a Project License (PPL) authorized by the UK Home Office. Mice were routinely screened for the absence of pathogens and *Helicobacter* species and were over 5 weeks of age when used.

**Induction of colitis.** *Hh* NCI-Frederick isolate 1A (strain 51449) was grown as described previously.^[@bib48]^ Mice were fed on two consecutive days with *Hh* 1A (∼1.0 × 10^8^ colony-forming units) by oral gavage and injected intraperitoneally with 1 mg anti-IL-10R (clone 1B1.2) mAb weekly, starting on day 0. Unless specified in the corresponding figures, mice were killed 2--3 weeks after infection.

**Histology.** Upon killing, samples of cecum and intact proximal, mid, and distal colon were fixed in phosphate-buffered 4% formalin. Next, 4--5 μm paraffin-embedded sections were stained with hematoxylin and eosin, and histopathology of the colon and cecum was assessed using a scoring system for epithelial hyperplasia, goblet cell depletion, leukocyte infiltration, and submucosal inflammation, as previously described.^[@bib48]^ Photomicrographs were taken using a Nikon Coolscope (Nikon, Tokyo, Japan).

**Isolation of leukocytes.** For lamina propria leukocyte isolation, the colon was opened longitudinally, washed, and cut into pieces. Pieces were washed twice in Hanks\' balanced salt solution supplemented with 4% fetal bovine serum, 100 U ml^−1^ penicillin/streptomycin, and 5 m[M]{.smallcaps} EDTA at 37 °C with shaking to remove epithelial cells. Tissue was then digested at 37 °C in a shaking incubator with 1 mg ml^−1^ type VIII collagenase (Sigma-Aldrich, Gillingham, UK) and 0.5 mg ml^−1^ DNase I in RPMI-1640 medium supplemented with 4% fetal bovine serum and 100 U ml^−1^ penicillin/streptomycin. Cells were then layered on a 40/80% Percoll gradient, centrifuged, and the interface was recovered. Cells were counted using a Casy Cell Counter and Analyzer Model TT (Innovatis, Roche Diagnostics, Burgess Hill, UK).

**Flow cytometry and cell sorting.** For surface staining, cells were stained in phosphate-buffered saline/0.1% bovine serum albumin/5 m[M]{.smallcaps} EDTA buffer with a fixable viability dye and a combination of the following antibodies: CD45 (30-F11), CD11c (N418), MHCII (M5/114.15.2), F4/80 (BM8), and TCRβ (H57-597) (all from eBioscience, Hatfield, UK); CD103 (M290), CD11b (M1/70), and Siglec-F (E50-2440) (all from BD Biosciences, Oxford, UK); Ly6G (1A8), Ly6C (HK1.4), CD64 (X54-5/7.1), CD4 (RM4-5), CD24 (M1/69), and CD206 (C068C2) (all from BioLegend, London, UK). Fc block (anti-CD16/CD32, eBioscience) was included to minimize nonspecific antibody binding. For intracellular cytokine staining of T cells, cells were incubated for 3.5 h in complete IMDM medium containing 0.1 μ[M]{.smallcaps} phorbol 12-myristate 13-acetate and 1 μ[M]{.smallcaps} ionomycin with 1:1,000 GolgiPlug and GolgiStop solutions (BD Biosciences) at 37 °C in a humidified incubator with 5% CO~2~. Following surface staining, cells were fixed and permeabilized with the Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD Biosciences) according to the manufacturer\'s instructions. Cells were stained for 50 min with antibodies to IL-17A (17B7, eBioscience) and IFNγ (XMG1.2, eBioscience). All cells were analyzed on a SORP LSRII (BD Biosciences) or sorted on a FACSAriaIII (BD Biosciences) to a purity of \>95%. Analysis was performed using FlowJo software (Tree Star, Ashland, OR).

**Quantitative PCR.** RNA was isolated from snap-frozen colonic tissue (combined proximal, mid, and distal colon sections), isolated lamina propria cells, BMDMs, or from FACS-sorted cells using the RNeasy Mini kit (QIAGEN, Manchester, UK) according to the manufacturer\'s instructions, including an on-column DNase I digestion step. Complementary DNA synthesis was performed using Superscript III reverse transcriptase (QIAGEN) or High-Capacity cDNA Reverse Transcriptase (Applied Biosystems, Life Technologies, Paisley, UK). Quantitative PCR reactions for the candidate genes were performed using TaqMan gene expression assays (Life Technologies). Complementary DNA samples were analyzed in duplicate using the CFX96 detection system (Bio-Rad Laboratories, Hemel Hempstead, UK) or ViiA 7 Real-Time PCR System (Life Technologies), and gene expression levels for each sample were normalized to HPRT. Mean relative gene expression was determined, and the differences were calculated using the 2ΔC(t) method. Primer pairs and probes were as follows: TaqMan Gene Expression Assays for mouse *Hprt* (Mm01545399_m1), *Il23a* (Mm00518984_m1), and (Mm01160011_g1).

**Quantitation of cytokine protein levels.** For detection of cytokines by the Flowcytomix Multiplex system (Life Technologies), 5 × 10^5^ leukocytes were cultured for 48 h in complete RPMI medium at 37 °C. Cytokines in the supernatant were detected using Simplex kits for mouse tumor necrosis factor-α, IL-1β, IL-17A, interferon-γ (IFNγ), and IL-22 according to the manufacturer\'s instructions and analyzed by flow cytometry. IL-23 protein levels were quantified using the mouse IL-23 ELISA Ready-SET-Go! kit (eBioscience).

**Quantitation of *H. hepaticus*.** *Hh* colonization levels were quantified in cecal contents collected upon killing. DNA was isolated using the DNA Stool kit (QIAGEN) and quantitative PCR with *Hh*-specific primers against the *cdtB* gene was performed as previously described.^[@bib48]^

**Depletion of macrophages with anti-CSF-1R mAbs.** Anti-CSF-1R mAb was purified from the culture supernatants of AFS98 hybridoma, kindly provided by Dr Miriam Merad (Mount Sinai School of Medicine, New York, NY). Mice were injected intraperitoneally with anti-CSF-1R mAb (AFS98) or rat IgG1 isotype control (HRPN, BioXcell, West Lebanon, NH) at doses of 1 mg per mouse on day −4 followed by 0.3 mg per mouse from day −3 to day 0. A group of mice was analyzed at day 0, whereas the remaining mice were infected with *Hh* and anti-IL-10R and continued to receive anti-CSF-1R treatment at 0.3 mg per mouse every second day until killing at day 4 or 14.

**Statistics.** Mann--Whitney *U-*test or one-way analysis of variance with Bonferroni\'s post-test correction was performed using GraphPad Prism version 6.02 for Windows (GraphPad Software, La Jolla, CA) as indicated. Differences were considered statistically significant when *P*\<0.05.
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![*Helicobacter hepaticus* (*Hh*)-driven inflammation alters the intestinal mononuclear phagocyte compartment. CX~3~CR1^GFP/+^ mice were infected with *Hh* and treated with anti-IL-10R monoclonal antibody (mAb), or with the respective single controls as indicated, and were compared with uninfected controls (Ctrl). Mice were analyzed after 2--3 weeks. (**a**) Colon histopathology scores. (**b**) Total number of colonic lamina propria cells per mouse. (**c**) Frequency of myeloid cell subsets among total colonic CD11b^+^ leukocytes. (**d**) Representative fluorescence-activated cell sorting (FACS) plots and (**e**) histograms of the indicated myeloid subsets: MHCII^+^ monocytes (CD11b^+^ CX~3~CR1^int^ Ly6C^hi^, red subset), macrophages (CD11b^+^ CX~3~CR1^hi^ Ly6C^lo^ cells, green subset), CD11b^+^ DCs (CD11c^+^ CD103^-^ CD11b^+^ CX~3~CR1^int^ cells, gray subset), and CD103^+^ DCs (CD11c^+^ CD103^+^ CX~3~CR1^-^ cells, orange subset). All cells were pregated on live CD45^+^ leukocytes, excluding neutrophils and eosinophils. Fluorescence minus one (FMO) controls for CD11b^+^ MHCII^+^ cells are shown. (**f**) Frequency of CD206^+^ cells among the indicated subsets determined by flow cytometry. Data points represent individual mice, bars indicate medians. All data are representative of at least two independent experiments. \*\**P*\<0.01, \*\*\**P*\<0.001 as determined by one-way analysis of variance (ANOVA) with Bonferroni\'s post-test. DC, dendritic cell; IL-10, interleukin-10; LPL, lamina propria leukocyte.](mi201565f1){#fig1}

![Interleukin-23 (IL-23) from CD11c^+^ cells drives *Helicobacter hepaticus* (*Hh*)-induced colitis. CD11c^IL-23+^ and CD11c^IL-23-^ mice were infected with *Hh* combined with anti-IL-10R monoclonal antibody (mAb) treatment and analyzed after 3 weeks. Uninfected mice served as control. (**a**) Representative micrographs of hematoxylin and eosin-stained sections (bar-200 μm) and histopathology scores of the colon and cecum. (**b**) Total number of lamina propria cells per mouse. (**c**) Spleen weight. (**d**) *Hh* colonization level quantified by quantitative PCR (qPCR). (**e**,**f**) Expression of cytokines assessed by (**e**) multiplex flow cytometric assay or (**f**) enzyme-linked immunosorbent assay (ELISA) on the supernatants of unstimulated lamina propria cells cultured for 48 h. Data points represent individual mice, bars indicate medians. Data are pooled from two independent experiments and are representative of four experiments. \*\**P*\<0.01, \*\*\**P*\<0.001 as determined by (**a--c**) one-way analysis of variance (ANOVA) with Bonferroni\'s post-test or (**d**--**f**) Mann--Whitney *U-*test. IFNγ, interferon-γ TNFα, tumor necrosis factor-α.](mi201565f2){#fig2}

![MHCII^+^ monocytes and pathogenic T cells are reduced in *Helicobacter hepaticus* (*Hh*)-infected and anti-IL-10R-treated CD11c^IL-23-^ mice. CD11c^IL-23+^ and CD11c^IL-23-^ mice were infected with *Hh* combined with anti-IL-10R monoclonal antibody (mAb) treatment and analyzed after 3 weeks. (**a**) Representative fluorescence-activated cell sorting (FACS) plots, frequencies among CD45^+^ leukocytes, and absolute numbers of the indicated myeloid subsets in the colonic lamina propria. (**b**) Frequencies of CD4^+^ T cells among CD45^+^ leukocytes. (**c**) Representative FACS plots and frequencies of IFNγ^+^, IFNγ^+^ IL-17A^+^, and IL-17A^+^ cells among CD4^+^ T cells upon restimulation with phorbol 12-myristate 13-acetate (PMA) and ionomycin. Data points represent individual mice, bars indicate medians. Data are representative of two independent experiments. \**P*\<0.05, \*\**P*\<0.01 as determined by Mann--Whitney *U-*test. IFNγ, interferon-γ IL, interleukin; MHCII, major histocompatibility complex class II; TCR, T cell receptor.](mi201565f3){#fig3}

![MHCII^+^ monocytes and macrophages are the major producers of interleukin-23 (IL-23) during *Helicobacter hepaticus* (*Hh*)-induced colitis. CD11c^IL-23+^ mice (Cre-GFP^+^) were infected with *Hh* combined with anti-IL-10R monoclonal antibody (mAb) treatment and analyzed 4 days after infection alongside uninfected controls (Ctrl). (**a**) Quantitative PCR (qPCR) analysis of *Il23a* mRNA expression in colonic tissue collected from five individual mice at the indicated time points. (**b**) Total number of lamina propria cells per mouse at day 4. (**c**) Representative fluorescence-activated cell sorting (FACS) plots and (**d**,**e**) frequencies of the indicated myeloid subsets (as defined in [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}) among colonic CD45^+^ leukocytes. (**f,g**) Representative FACS plots of CD11c-Cre-associated green fluorescent protein (GFP) expression vs. (**f**) CD11c and (**g**) MHCII. (**h**) qPCR analysis of *Il23a* mRNA expression by Cre-GFP^+^ and Cre-GFP^-^ cells FACS-sorted from colonic leukocytes. (**i**) Frequency of CD11c-Cre-associated GFP expression among the indicated colonic myeloid subsets. Rectangle indicates Cre-positive subsets that were selected for further analysis in **j**. (**j**) qPCR analysis of *Il23a* mRNA expression by myeloid subsets FACS-sorted from CD11c^IL-23+^ and CD11c^IL-23-^ mice. Statistics comparing cells from CD11c^IL-23+^ and CD11c^IL-23-^ mice are shown. (**k**) qPCR analysis of *Il23a* mRNA expression by FACS-sorted MHCII^-^ and MHCII^+^ monocytes. Data points represent individual mice, bars indicate medians. All bar charts of FACS-sorted cells represent the mean±s.e.m. of 10--15 pooled mice, sorted in two biological replicates. Data are representative of two independent experiments. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, as determined by (**a**, **j**) one-way analysis of variance (ANOVA) with Bonferroni\'s post-test or (**b--h**, **k**) Mann--Whitney *U-*test. DC, dendritic cell; MHCII, major histocompatibility complex class II.](mi201565f4){#fig4}

![Interleukin-23 (IL-23) production during colitis is restricted to CX~3~CR1-expressing CD64^+^ subsets. CX~3~CR1^GFP/+^ mice were infected with *Helicobacter hepaticus* (*Hh*) combined with anti-IL-10R monoclonal antibody (mAb) treatment and analyzed 2 weeks after infection alongside uninfected controls (Ctrl). Colonic lamina propria cells were sorted by flow cytometry and *Il23a* mRNA expression was analyzed by quantitative PCR (qPCR). (**a**) *Il23a* mRNA expression and representative fluorescence-activated cell sorting (FACS) plots of the following sorted populations: (1) MHCII^+^ monocytes (Mono), (2) Ly6C^lo^ CX~3~CR1^int^ macrophages/DCs, (3) CX~3~CR1^hi^ macrophages, and (4) CD103^+^ DCs. (**b**) *Il23a* mRNA expression and representative FACS plots of the following sorted populations: (1) CX~3~CR1^int^ MHCII^+^ CD64^-^ and (2) CX~3~CR1^int^ MHCII^+^ CD64^+^ cells. Bar charts represent the mean+s.e.m. of 10--15 pooled mice, sorted in two biological replicates. Data are representative of three independent experiments. \*\**P*\<0.01, \*\*\**P*\<0.001, as determined by one-way analysis of variance (ANOVA) with Bonferroni\'s post-test. DC, dendritic cell; Macs, macrophages; MHCII, major histocompatibility complex class II; Mono, monocyte; NS, not significant.](mi201565f5){#fig5}

![*Batf3*-dependent dendritic cells (DCs) are dispensable for the production of interleukin-23 (IL-23) in *Helicobacter hepaticus* (*Hh*)-driven colitis. Wild-type (WT) and *Batf3*^−/−^ mice were infected with *Hh* combined with anti-IL-10R monoclonal antibody (mAb) treatment and analyzed after 2 weeks alongside uninfected controls (Ctrl). (**a**) Representative fluorescence-activated cell sorting (FACS) plots and (**b**) frequencies and numbers of CD103^+^ CD11b^-^ and CD103^+^ CD11b^+^ cells among CD45^+^ colonic leukocytes. (**c**) Total number of lamina propria cells per mouse. (**d**) Histopathology scores of the colon. Data points represent individual mice, bars indicate medians. \**P*\<0.05 as determined by Mann--Whitney *U-*test, NS, not significant.](mi201565f6){#fig6}

![Macrophages share functional redundancy with MHCII^+^ monocytes for interleukin-23 (IL-23) production. CX~3~CR1^GFP/+^ mice were treated with a blocking anti-CSF-1R monoclonal antibody (mAb) or isotype (Iso) control and analyzed (**a**--**e**) 4 days or (**f**, **g**) 2 weeks after *Helicobacter hepaticus* (*Hh*) and anti-IL-10R mAb treatment. (**a**) Representative fluorescence-activated cell sorting (FACS) plots and (**b**) frequencies among CD45^+^ leukocytes of the indicated myeloid subsets, as defined in [Figure 1c](#fig1){ref-type="fig"}. (**c**) Total number of colonic lamina propria cells per mouse. (**d**) Frequencies of neutrophils among CD45^+^ cells. (**e**) Quantitative PCR (qPCR) analysis of *Il23a* mRNA expression by total colonic lamina propria cells analyzed at day 4. (**f**) Total number of colonic lamina propria cells per mouse 2 weeks after *Hh* and anti-IL-10R mAb treatment. (**g**) Colonic histopathology scores. Data points represent individual mice, bars indicate medians. Data are pooled from two experiments and representative of three independent experiments. \**P*\<0.05, \*\**P*\<0.01, as determined by Mann--Whitney *U-*test. CSF, colony-stimulating factor; DC, dendritic cell; Macs, macrophages; MHCII, major histocompatibility complex class II; NS, not significant; Uninf, uninfected.](mi201565f7){#fig7}
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